| Location: | Federal |
|---|---|
| Posted: | Oct 28, 2025 |
| Due: | Dec 8, 2025 |
| Agency: | Government of Canada |
| Type of Government: | State & Local |
| Category: |
|
| Solicitation No: | W6369-26-A029 |
| Publication URL: | To access bid details, please log in. |
Description
The Strategic Medical Countermeasures Program (SMCP), on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp) has a requirement for Potassium Iodide tablets for use as a thyroid blocking agent for use in nuclear emergencies which involve the release of radioiodine.
The Contract Period will be from contract award to 31 March 2030.
The Crown retains the rights to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.
Applicable trade agreements:
Canadian Free Trade Agreement
Canadian-Colombia Free Trade Agreement
Canada-Honduras Free Trade Agreement
Canada-Panama Free Trade Agreement
Canada-Korea Free Trade Agreement
Canada-Peru Free Trade Agreement
Canada-Chili Free Trade Agreement
The estimated contract period will be 51 month(s), with a proposed start date of 2026/01/01.
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
Are you interested in partnering with other businesses for this opportunity? Add your company to the list of businesses who are interested in partnering .
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use .

With GovernmentContracts, you can: